BBOTVSPFSA• 6 Months (Normalized)
BBOT vs PFSA (BridgeBio Oncology Therapeutics Inc. vs Profusa Inc.)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.5
-60.47%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
PFSA Performance $1.66
-98.42%
Profusa Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+37.95 pts
BBOT outperforming by 37.95 percentage points
BBOTPFSA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT PFSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | BBOT Price | BBOT Gain (%) | PFSA Price | PFSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.50 | -60.47% | $1.66 | -98.42% | +37.95% |
| Oct 05, 2026 | $3.60 | -59.35% | $1.75 | -98.33% | +38.98% |
| Oct 02, 2026 | $3.89 | -56.07% | $1.69 | -98.39% | +42.32% |
| Sep 30, 2026 | $4.10 | -53.70% | $1.98 | -98.11% | +44.41% |
| Sep 29, 2026 | $3.92 | -55.73% | $2.27 | -97.84% | +42.11% |
| Sep 28, 2026 | $3.81 | -56.97% | $1.69 | -98.39% | +41.42% |
| Sep 25, 2026 | $3.95 | -55.39% | $2.18 | -97.92% | +42.53% |
| Sep 24, 2026 | $3.99 | -54.94% | $3.03 | -97.11% | +42.17% |
| Sep 23, 2026 | $4.16 | -53.02% | $2.05 | -98.05% | +45.03% |
| Sep 22, 2026 | $4.66 | -47.37% | $2.17 | -97.93% | +50.56% |
| Sep 21, 2026 | $4.66 | -47.37% | $1.94 | -98.15% | +50.78% |
| Sep 18, 2026 | $4.77 | -46.13% | $1.91 | -98.18% | +52.05% |
| Sep 17, 2026 | $4.89 | -44.78% | $1.80 | -98.29% | +53.51% |
| Sep 16, 2026 | $4.76 | -46.25% | $1.78 | -98.30% | +52.05% |
| Sep 15, 2026 | $4.88 | -44.89% | $1.83 | -98.26% | +53.37% |
Page 1 of 9